Neonatal Biomarkers Study (NBS)

Neonatal Biomarkers Study (NBS)

Contact

 If you are interested in participating in the study or want to learn more, please get in touch. Contact us
This study is no longer recruiting.

Description
This pilot study is investigating the feasibility of a prospective biomarker study in the CICU by measuring enrollment of subjects, as well as the looking at outcomes. The goal of this study is to risk stratify neonates with congenital heart disease requiring neonatal cardiopulmonary bypass for poor outcomes in order to appropriately tailor medical care and for possible future trials.

Eligibility and criteria
IRB Number:
20-017388
Clinical trial phase:
Pilot
Official title:
Development of a Plasma Biomarker Risk Profile for Neonates Requiring Cardiopulmonary Bypass for Congenital Heart Disease

What to expect


Related specialties
Smiling CHOP patient holding shopping bag

We need families like you

Your time and participation make a difference in supporting the work of the Research Institute and children in our community. Learn more about opportunities to participate in our research.